Drug
Saruparib
Saruparib: highest development phase Phase 3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Saruparib NCT06120491 | Phase 3 | Metastatic Castration-Sensitive Prostate Cancer |
Latest
No recent events.
Follow Saruparib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.